Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
1002
-
Total 13F shares, excl. options
-
89.9M
-
Shares change
-
+1.23M
-
Total reported value, excl. options
-
$54.4B
-
Value change
-
+$778M
-
Put/Call ratio
-
1.3
-
Number of buys
-
526
-
Number of sells
-
-392
-
Price
-
$605.18
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q3 2021
1,132 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2021.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,002 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.9M shares
of 105M outstanding shares and own 85.66% of the company stock.
Largest 10 shareholders include FMR LLC (11.1M shares), BlackRock Inc. (9.37M shares), VANGUARD GROUP INC (8.07M shares), Capital World Investors (5.32M shares), STATE STREET CORP (4.64M shares), JPMORGAN CHASE & CO (4.1M shares), WELLINGTON MANAGEMENT GROUP LLP (3.37M shares), LOOMIS SAYLES & CO L P (2.76M shares), GEODE CAPITAL MANAGEMENT, LLC (1.74M shares), and PUTNAM INVESTMENTS LLC (1.34M shares).
This table shows the top 1002 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.